Navigating the metastatic breast cancer treatment landscape

This webinar is focus on navigating the metastatic breast cancer treatment landscape, with a focus on optimising patient care with Enhertu (trastuzumab deruxtecan) for HER2-positive and HER2-low metastatic breast cancer.